- 工作地点：北京
- 职位：多肽研究专员
- 信息来源：前程无忧
说明：
此信息由前程无忧审核并发布（查看原发布网址），应届生求职网转载该信息只是出于传递更多就业招聘信息，促进大学生就业的目的。如您对此转载信息有疑义，请与原信息发布者前程无忧核实，并请同时联系本站处理该转载信息。
1.负责多肽制备合成的研究工作；
2.负责产品的工艺优化与放大。
职位要求：
1.有机合成、化学、生物化学等相关专业，硕士应届毕业生；
2.能够熟练的检索、运用各类中、英文化学文献；
3.具有良好的个人品质、团队合作精神及沟通能力；
4.工作态度踏实，能适应紧张的工作，能够认真仔细的完成交给的每一项工作。
如何写一份简单、直接、高效的求职信？
公司简要介绍：
扶素生物技术有限公司成立于2002年，是中国领军的生物技术企业之一。基于计算机药物设计，公司致力于研发及产业化治疗重大病毒性疾病（例如艾滋病、乙肝、丙肝等）的专利药物。
基于对现有药物结构、药物靶点结构以及其相互作用的研究，扶素生物设计了活性高且安全性好的药物。这种模式可使扶素生物在更短的时间内以更低的研发费用设计出更优的药物。
扶素生物产品线中的主导项目为艾滋病病毒膜融合抑制剂西夫韦肽，正在开展临床试验。
FusoGen Pharmaceuticals, Inc., founded in 2002, is a leading biotech company in China. The company is dedicated to the discovery, development, and commercialization of novel therapeutics against serious viral infections, such as HIV, hepatitis B, and hepatitis C, by the approach of computer drug design.
Based on the structural knowledge of existing drugs, drug targets, and their interactions, FusoGen designs drugs with superior activity and reduced toxicity. We believe this model enables FusoGen to develop better drugs in shorter time and with much reduced R&D cost.
The leading drug candidate in FusoGen's drug pipeline is Sifuvirtide, an HIV fusion inhibitor, which is currently undergoing Phase II clinical trial in China.
基于对现有药物结构、药物靶点结构以及其相互作用的研究，扶素生物设计了活性高且安全性好的药物。这种模式可使扶素生物在更短的时间内以更低的研发费用设计出更优的药物。
扶素生物产品线中的主导项目为艾滋病病毒膜融合抑制剂西夫韦肽，正在开展临床试验。
FusoGen Pharmaceuticals, Inc., founded in 2002, is a leading biotech company in China. The company is dedicated to the discovery, development, and commercialization of novel therapeutics against serious viral infections, such as HIV, hepatitis B, and hepatitis C, by the approach of computer drug design.
Based on the structural knowledge of existing drugs, drug targets, and their interactions, FusoGen designs drugs with superior activity and reduced toxicity. We believe this model enables FusoGen to develop better drugs in shorter time and with much reduced R&D cost.
The leading drug candidate in FusoGen's drug pipeline is Sifuvirtide, an HIV fusion inhibitor, which is currently undergoing Phase II clinical trial in China.
YingJieSheng.COM
快乐是一种选择，我们可以在任何时间、任何地点和状况中做这种选择，因为每一项经验都可被建构出一种正面的意义，我们可以由任何人、事、物上汲取快乐。 [摘自 快乐的秘密]
